Modulation of c‐myc Transcription by Triple Helix Formationa
- 1 October 1992
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 660 (1), 57-63
- https://doi.org/10.1111/j.1749-6632.1992.tb21057.x
Abstract
The human c-myc oncogene promoter was used as a model with which to study the mechanism of action of oligodeoxyribonucleotides targeted to a gene regulatory region. The nuclease-hypersensitive element, NHE, lying -115 bp from the P1 promoter of the human c-myc gene, is known to be required in cis for transcription of the gene from both P1 and P2 promoters (Fig. 1). Inhibition of c-myc transcription by an oligonucleotide designed to bind to NHE by triplex formation has been observed in a cell-free transcription assay. Using a reconstituted transcription system with the semipurified PuF transcription factor whose site of interaction resides within the NHE, it is shown here that the oligonucleotide inhibits PuF-mediated transcription. These findings, together with data presented elsewhere showing that: (1) PU1 binds to cloned DNA fragments to form a colinear triplex; (2) PU1 inhibits transcription in nuclear extracts; (3) triple helix formation inhibits the binding of PuF to its target NHE element in an in vitro binding competition assay (E. Postel, R. Durland, and M. Hogan, submitted); (4) triplex formation at the NHE target site can occur in living HeLa cells treated with the triplex-forming PU1 oligomer, and (5) c-myc mRNA synthesis in these treated cells is repressed, clearly support the proposed model in which the oligonucleotide targeted against the c-myc NHE promoter region binds to form a triplex, thereby blocking access to the regulatory protein PuF. This results in promoter-sensitive repression of transcriptional activation of the c-myc gene. The potential for manipulation of gene expression by oligonucleotides targeted to a DNA sequence of the c-myc oncogene promoter and other gene promoters is clear.This publication has 11 references indexed in Scilit:
- Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.Proceedings of the National Academy of Sciences, 1991
- Binding of triple helix forming oligonucleotides to sites in gene promotersBiochemistry, 1991
- Ribonucleoprotein and protein factors bind to an H-DNA-forming c-myc DNA element: possible regulators of the c-myc gene.Proceedings of the National Academy of Sciences, 1989
- A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor.Molecular and Cellular Biology, 1989
- The chemistry and biology of unusual DNA structures adopted by oligopurine · oligopyrimidine sequencesThe FASEB Journal, 1988
- Site-Specific Oligonucleotide Binding Represses Transcription of the Human c- myc Gene in VitroScience, 1988
- DNA H form requires a homopurine–homopyrimidine mirror repeatNature, 1987
- Regulatory elements that modulate expression of human c-myc.Genes & Development, 1987
- DNA structure equilibria in the human c-myc geneBiochemistry, 1987
- Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in burkitt lymphomaCell, 1984